This post was originally published on this site
Here are some of the biggest movers of Monday.
Stock gainers:
Carnival Corp.’s
CCL,
stock rallied 13% to lead S&P 500 gainers after two Wall Street analysts turned bullish, saying growing demand is no longer just about a postpandemic recovery.
Biogen Inc.
BIIB,
shares rallied 2% following a full-day halt during the regular session as a Food and Drug Administration committee convened to vote on an approval recommendation for the Alzheimer’s drug candidate the biotech makes with Eisai Co.
ESALF,
The committee voted unanimously to recommend approval, and Biogen shares took off when they were unhalted.
Shares of Chinook Therapeutics Inc.
KDNY,
rose 58% to $40.02 after it agreed to be bought by Novartis
NVS,
for up to $3.5 billion.
Tesla Inc.’s
TSLA,
stock rose 1.2% to put it on track for a record 12th straight day of gains.
Oracle Corp.’s
ORCL,
stock rose 6%. It is slated to report fiscal fourth-quarter earnings after the bell on Monday. Analysts polled by FactSet expect the software giant to report adjusted earnings of $1.58 a share on sales of $13.7 billion.
Carvana
CVNA,
shares rose 8%, following a 21% downturn on Friday for the volatile used-car retailer.
GameStop Corp.’s
GME,
stock rose 6% as the video game retailer and sometime meme-stock darling continued its snapback following the leadership changes that saw activist investor Ryan Cohen elected as executive chair.
Advanced Micro Devices Inc.
AMD,
is poised to capitalize on the wave of interest around artificial intelligence, and that has one analyst taking a rosier view of its stock, which was last up 2%.
Stock decliners:
Teck Resources Ltd.’s
TECK,
TECK.B,
stock edged lower as Glencore
GLEN,
lodged a bid for its coal unit, in addition to a $23 billion offer for the whole company.
Nasdaq Inc.’s
NDAQ,
stock fell 12% to lead S&P 500 decliners after the securities-trading, -clearing and -listing company’s $10.5 billion deal to buy software company Adenza from private-equity firm Thoma Bravo included about $5 billion worth of stock.
JPMorgan Chase & Co.’s
JPM,
stock slid 0.4% after the bank said it has reached a settlement in the class-action lawsuit Jane Doe 1 v. JPMorgan Chase. A source confirmed to MarketWatch that the settlement amount is $290 million, as was initially reported by the Wall Street Journal.
KeyCorp’s
KEY,
stock slid 6% after Chief Financial Officer Clark Khayat said at the Morgan Stanley U.S. Financials, Payments and CRE Conference that net interest income would be softer than expected in the second quarter. The stock was the second-biggest S&P 500 decliner.
